Formula I Compounds for Mitotic Arrest in Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatment methods, such as chemotherapy, radiation therapy, and surgery, have undesirable side effects and varying success rates, necessitating the development of new approaches for effectively treating cancer and diseases associated with cellular proliferation.
Innovation Solution
The development of specific compounds of Formula (I) and their pharmaceutical compositions, which can be used to treat cancer by administering them to patients, potentially arresting mitosis and altering DNA content, thereby addressing the limitations of existing cancer treatment methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional cancer treatment methods (chemotherapy, radiation therapy, surgery) are used, then cancer can be treated, but undesirable side effects occur and success rates vary
Solution Approach 1:
The patent applies parameter changes by developing novel chemical compounds with specific molecular structures (Formula I) that differ from traditional chemotherapy agents. These compounds feature distinct structural parameters including specific ring systems, substituent groups, and molecular weight ranges that enable selective targeting of cancer cells while reducing harm to normal tissues, thereby improving success rates and reducing side effects
Solution Approach 2:
The patent employs composite materials by creating pharmaceutical compositions that combine the novel compound of Formula I with pharmaceutically acceptable excipients, carriers, and adjuvants. This composite approach enhances the therapeutic efficacy and bioavailability of the active compound while minimizing toxic effects, addressing both the reliability and harmful factors parameters
2Reliability
If new compounds of Formula (I) are developed and administered, then mitosis can be arrested and DNA content altered to treat cancer, but the complexity of drug development increases
Solution Approach 1:
The patent applies segmentation by dividing the complex molecular structure of Formula I into distinct functional segments: the core heterocyclic ring system, substituent groups (R1-R6), and linker moieties. This segmentation allows for systematic optimization of each component's contribution to mitotic arrest and DNA alteration while managing overall structural complexity through modular design
Solution Approach 2:
The patent demonstrates universality by designing the compound of Formula I to perform multiple therapeutic functions simultaneously: arresting mitosis, altering DNA content, and inducing apoptosis in cancer cells. The broad scope of R1-R6 substituents allows a single core structure to address various cancer types through targeted modifications, reducing the need for multiple separate drugs
Data Source
AI summary
The present disclose includes, among other things, compounds that treat or lessen the severity of cancer, pharmaceutical compositions and methods of making and using the same.